Ligand Pharmaceuticals

$151.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$4.03 (+2.74%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LGND and other stocks, options, and ETFs commission-free!

About LGND

Ligand Pharmaceuticals Incorporated Common Stock, also called Ligand Pharmaceuticals, is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

CEO

John L. Higgins

Employees

155

Headquarters

San Diego, California

Founded

1987

Market Cap

2.69B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

139.12K

High Today

$153.69

Low Today

$147.62

Open Price

$147.69

Volume

116.25K

52 Week High

$219.75

52 Week Low

$78.26

Analyst Ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

LGND Earnings

$0.00

$0.54

$1.08

$1.62

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, Pre-Market